Reference

AMET works diligently to keep the following information updated with the most current medical aesthetic news.  This information has been supplied by numerous sources. AMET is not affiliated with any such sources, and the information provided does not reflect the views of AMET.  The function of this page is to simply provide information, and AMET does not accept responsibility or liability for any views/claims/rumors/errors that appears herein.  

Search

6/8/2014
Valeant and Ackman Departing From Usual Playbook in Pursuit of Allergan
From the moment it was announced, the $53 billion joint bid for Allergan, the maker of Botox, made by Valeant Pharmaceuticals and the hedge fund manager William A. Ackman, was highly unconventional.

6/8/2014
Are You Calling Yourself a Medical Esthetician?
Many states explicitly prohibit estheticians from providing medical services, so advertising that you do so may be considered misleading and, therefore, in violation of state law

5/6/2014
Reconstitution is key to optimizing neurotoxin results
IncobotulinumtoxinA (Xeomin, Merz) is equivalent to onabotulinumtoxinA (Botox, Allergan) in efficacy and safety, but the former product needs to be reconstituted in a different fashion from onabotulinumtoxin A to achieve equivalent efficacy.

4/15/2014
Navigating neurotoxins' differences
With three neurotoxins on the market, it is important to understand their similarities and differences in both the way they act and pricing. Dermatology Times put together a panel to discuss how they use Botox, Dysport and Xeomin in their practice.

4/15/2014
Understanding Inflammation The Root Cause of Skin Aging
What's really aging skin? Is it possible there's one root cause responsible behind skin aging, diseases and other challenges? This article by Skin, Inc. addresses the types, good and bad aspects, how to tame and protect skin from inflammation.

11/27/2012
Pokertox: Botox For Gambler's Poker Face
A doctor of aesthetic medicine in New York is taking a gamble that poker players are going to be the next big growth market for botox.

3/20/2012
Injunction Throws a Wrinkle in Merz's Plan to Launch Xeomin
About a week before Merz was slated to introduce Xeomin at a major medical meeting, Botox manufacturer Allergan has won an immediate injunction blocking the company from selling this product, which is a Botox competitor.The injunction prohibits Merz from selling or soliciting purchases of its Botox alternative, Xeomin, in the facial aesthetics market for 10 months

11/30/2011
Move Over, Botox: There’s a New Wrinkle Filler in Town
Xeomin has been FDA approved specifically for the vertical frown lines between the eyebrows. Apparently, this product was previously approved for use in adults with cervical dystonia, a condition in which spasm and contractions of the neck muscles produce a very uncomfortable and unsightly appearance. Likewise, it had been approved for blepharospasm, which is involuntary flickering of the orbicularis muscle that surrounds the eye.

11/30/2011
Botulinum toxins function similarly, but aren't interchangeable
Coral Gables, Fla. — Although many forms of botulinum toxin available worldwide function similarly, the products are not interchangeable, as they have different protein sizes, diffusion characteristics, potencies and effects, says Fredric S. Brandt, M.D., a Coral Gables, Fla., dermatologist.

11/30/2011
FDA OKs Belotero for correction of facial wrinkles, folds
Washington — The Food and Drug Administration has approved the hyaluronic acid-based filler Belotero Balance (Merz Aesthetics) for the correction of moderate-to-severe facial wrinkles and folds, the company announced.

10/24/2011
Topical Neurotoxin Erases Crow's Feet
The most recent phase 2 studies on a topically delivered botulinum toxin type A lend clinical support to an investigational product that physicians might use one day to essentially wipe away crow's feet wrinkles around the eyes, according to a consultant for the developer.

10/24/2011
IncobotulinumtoxinA approved for glabellar line-related use
The FDA has approved the use of incobotulinumtoxinA (Xeomin, Merz Aesthetics) to improve the appearance temporarily of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults.

10/24/2011
Injectables serve as nonsurgical option for beautifying the nose
Injectables do not replace rhinoplasty, but they offer a viable alternative for those interested in nasal reshaping who are unwilling to undergo surgery, say Vince Bertucci, M.D., and Jean-François Tremblay, M.D.

10/24/2011
Restylane Gets FDA Nod for Lip Augmentation
Medicis Pharmaceutical Corp announced that the FDA has approved its premarket approval application (PMA) supplement to expand the approved use of the Restylane hyaluronic acid dermal filler to include lip augmentation

6/6/2011
NJ Lawmakers:
Minors in New Jersey won't be able to get Botox injections without a doctor saying it's medically necessary under a bill moving through the Assembly.

3/2/2011
Novel aesthetic options expect to make a splash in U.S. this year
Novel aesthetic options expected to make a splash in the United States in 2011 include new hyaluronic acid (HA) fillers, a new topical treatment for redness and a recently approved device for nonsurgical facelifting.

3/2/2011
Creative filling techniques rival surgical facelift results
Once used as the go-to tools for filling facial lines and crevasses, fillers are now, for some facelift candidates, replacing the scalpel.

3/2/2011
Patient age, volumizing needs drive injectable filler choice
As patients' faces change with age, so, too, should their options for treating lines and wrinkles.

3/2/2011
Non-Surgical Facial Procedures Spike Dramatically in 2010
Annual Survey of the American Academy of Facial Plastic and Reconstructive Surgery Finds More Patients Opting for Non-Surgical Procedures to Delay Surgery

1/13/2011
Landmark Study on Nonsurgical Eyelid Lift Published by Dr. Alexander Donath
Study proves for first time that Restylane lasts nearly 2 years for treating dark circles under eyes

1/13/2011
ASAPS: Injectables to grow in 2011
The popularity of injectable aesthetic fillers and toxins will continue to increase in 2011 as products evolve and new players enter the U.S. market

11/9/2010
Clinique Enters Medical Forum
The global medical aesthetics company Allergan has collaborated with prestige cosmetics brand Clinique Laboratories to create a new collection of medical products

11/9/2010
Are facelifts a thing of the past?
Less invasive procedures such as Botox injections and laser treatments are threatening to eradicate a classic of cosmetic surgery. Facelifts 'belong to my mother's generation, women in their 70s and beyond,' says one fortysomething

11/9/2010
If you want to get ahead, get Botox
Boardroom big-hitters tend to look young – prompting ageing rivals to turn to surgery

10/29/2010
Alternatives to surgery remain popular among patients, experts say
Noninvasive procedures — specifically, filling agents — are maintaining their popularity with patients

10/29/2010
New hyaluronic acid gel outperforms bovine collagen
A new cohesive polydensified matrix hyaluronic acid (CPMHA, Belotero Balance; Merz) has outlasted bovine collagen in a 24-week study of nasolabial fold (NLF) correction and performed well in a 1.5-year follow-up study, according to Rhoda S. Narins, M.D., director of the Dermatology Surgery and Laser Center, White Plains, N.Y.; clinical professor of dermatology, New York University School of Medicine; and lead author of the studies.

10/3/2010
Cosmetic surgery market predicted to double by 2017
The market for cosmetic surgery, facial aesthetics and lasers is expected to almost double in size and to exceed $3 billion over the next seven years.

8/28/2010
Informed consent ensures patients understand risks, benefits of permanent fillers
Expert suggests more detailed discussions with patients prior to administering permanent fillers

8/28/2010
Realistic aesthetic goals allow for natural-looking cosmetic rejuvenation outcomes
Beauty is in the eye of the beholder. However, different cultures and societies have varying ideals of beauty, and it is not uncommon that these differences in ideals result in highly variable aesthetic outcomes seen in cosmetic patients.

7/31/2010
New hyaluronic acid filler formulation rehydrates skin, boosts volume
Juvéderm Hydrate composed of 13.5 mg/g uncross-linked HA and 0.9 percent mannitol, resulting in reduced free-radical degradation of HA where injected

7/31/2010
Novel polycaprolactone dermal filler gains popularity in Europe
PCL found in Ellansé is the same material found in some resorbable sutures, other surgical devices

7/27/2010
Generic Latisse Competitor Applies for FDA Approval
An unnamed drug maker has applied for US regulatory approval to sell a generic version of Allergan Inc's eyelash-enhancing drug Latisse before its patent protection expires.

7/27/2010
Allergan's Botox Nears U.S. Approval To Treat Migraines
U.S. regulators are expected to soon approve Botox, the well-known cosmetic drug, for use in its first major medical application, boosting the fortunes of its maker, Allergan (AGN).

6/30/2010
New hyaluronic acid fillers boost cosmetic treatment options
New fillers, including even more hyaluronic acid (HA) fillers, as well as new toxins are expected to enter the U.S. market within the next year, according to William Philip Werschler, M.D., F.A.A.D., assistant professor of clinical medicine and dermatology, University of Washington School of Medicine, Seattle.

6/30/2010
Variety of dermal filler options helps meet specific skincare needs
With a variety of dermal fillers now available to dermatologists, it may be difficult to choose the right one. When a patient comes in, it is best to discuss what changes he or she is trying to achieve, says Ruth Tedaldi, M.D., who practices in Wellesley, Mass.

6/28/2010
Study Sees Anti-aging Effects
The results of a new landmark study published in the March 2010 issue of Dermatologic Surgery, the official publication of the American Society for Dermatologic Surgery (ASDS), confirm that a single, multisyringe treatment session administering facial fillers yields a quantifiable reduction in apparent age.

6/23/2010
Heidi A. Waldorf, MD, On Small-Vessel Sclerotherapy
Despite the popularity of lasers in treating spider veins, one should not overlook the art of sclerotherapy.

6/23/2010
For Young Tanners Wrinkles Are Scarier Than Skin Cancer
What's the most effective way to convince young women to cut back on their indoor tanning, a habit that hikes their risk of melanoma, the deadliest form of skin cancer, by 75 percent? Warn them that it will cause leathery, wrinkled skin.

6/21/2010
The Art of the TCA Chemical Peel
The process is part art, part chemistry

6/21/2010
Warning: Hydrelle Complications
I am issuing a personal warning about the soft tissue filler, Hydrelle, made by Anika Therapeutics and distributed by Coapt Systems.

6/19/2010
Fillers with lidocaine among latest injectable advancements
The U.S. injectables market has added lidocaine-containing versions of popular hyaluronic acid (HA) fillers, and additional fillers are expected to enter the market, an expert says.

6/19/2010
Botulinum toxin to treat dimpling of chin appears effective, safe
Treating chin dimpling can be a challenge, but a simple therapeutic approach using botulinum toxin coupled with a change in mimicking habits by the patient proves to relax the musculature in the chin area, resulting in significant, lasting aesthetic improvements.

6/19/2010
New injection technology delivers fillers with more precision, less pain
An automated injection system is allowing aesthetic physicians to inject fillers in a constant and controlled fashion, helping doctors achieve better aesthetic outcomes with significantly less pain perceived by the patient.

6/16/2010
Aquamid Submitted for FDA Approval
Contura International A/S, Soeborg, Denmark, last week announced that it has submitted a Premarket Approval Application (PMA) for Aquamid to the FDA requesting marketing approval in the United States for the aesthetic treatment of moderate to severe facial wrinkles and folds.

5/4/2010
Botox Reduces Wrinkles Using Less Frequent Doses
After 2 years of treatment at recommended intervals, patients can potentially cut the frequency, and thus the cost, of their Botox treatments by half, according to recent research presented by Roger A. Dailey, MD, FACS, professor and Lester Jones Endowed Chair of oculofacial plastic surgery in the OHSU School of Medicine.

4/24/2010
Avoiding Dissatisfied Clients
The best strategy for dealing with difficult patients is to avoid them in the first place

4/24/2010
FDA Approves Polidocanol for Spider Veins
The FDA announced last week its approval of Asclera (polidocanol) injection for the treatment of spider veins (tiny varicose veins less than 1 mm in diameter) and reticular veins (those that are 1 mm to 3 mm in diameter). Asclera works by damaging the cell lining of blood vessels which closes the vessel.

4/17/2010
Economy slows cosmetic procedures only slightly
The recession is having an effect on the number of cosmetic procedures done — but not much of one, HealthDay News reports.

4/16/2010
Plastic Surgery Gaining Acceptance In the African-American Community
The changing face of cosmetic patients is largely attributed to improving socioeconomic status among minority communities, images of

4/16/2010
AAD: Hyaluronic Acid Increases Fibroblast Activity
Recent research suggests how the popular skin filler hyaluronic acid works to rejuvenate photoaged skin, and nanotechnology may have potential for use in cosmetic products and topical medical treatments

4/14/2010
Could Gum-chewing Cause Wrinkles; Shorten Filler Lifespan?
It freshens your breath and helps you quit smoking, but some cosmetic surgeons believe chewing gum does one more thing: It gives you wrinkles.

4/14/2010
Men Jumping on Brotox Bandwagon
South Florida men going for cosmetic procedures

3/26/2010
Dysport Versus Botox
Several practitioners sound off about using Dysport, as well as similarities and differences to Botox Cosmetic

3/25/2010
Injectable Procedures Up in 2009
Injectable procedures appear to have experienced a boost during the 4th quarter of 2009, reflecting the common experience among surgeons that injectables increased while surgery decreased during the tough economy.

3/18/2010
Allergan, Inc. Announces the JUVEDERM(R) 'Switch Up' Campaign Educating Women on the Positive Impact Small Changes Have on Personal Appearance
Television personality Dayna Devon embraces turning 40 this year and is sharing personal tips on how women can keep their look fresh to portray their best selves

3/16/2010
Interim results of Artefill study 'encouraging'
There are encouraging 18-month interim results from a prospective five-year safety and patient-satisfaction study on Artefill (collagen gel/polymethylmethacrylate, Suneva Medical) for use in correcting nasolabial folds, PR Newswire reports.

3/1/2010
Study Showed Sculptra(R) Aesthetic Effectively Corrects Nasolabial Folds and Other Facial Wrinkles
Results published in today's online issue of the Journal of American Academy of Dermatology showed that treatment with Sculptra®Aesthetic (injectable poly-L-lactic acid) was significantly more effective than a human-derived collagen treatment CosmoPlast®* in correcting shallow to deep nasolabial fold (NLF) wrinkles (smile lines). In addition, this study demonstrated that the effect in correcting the NLF wrinkles with SculptraAesthetic can last for up to 25 months.

3/1/2010
Botox clinics told to tighten up on safety
Rogue practitioners face crackdown but charities say self-regulation is not enough

3/1/2010
Face value: Why more men are getting Botox
A growing number of males are turning to injections and laser treatments in an effort to maintain job security

2/19/2010
Report: Antiaging Key Motivator in Skin Care Purchases
Antiaging continues to be a key motivator for purchase among women skin care users, according to a recent report from The NPD Group, a market research company in Port Washington, NY. Seventy-five percent of female skin care users “use skincare products to look the best they can for their age,” according to the report.

2/9/2010
FDA Cracks Down on Physician for Dysport Praise
The dermatologist's statements in the media suggested that Dysport was safe and effective before it was approved, the FDA claims

2/3/2010
Medicis Receives Approval for RESTYLANE(R) and PERLANE(R) With Lidocaine
Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the dermal fillers RESTYLANE®-L and PERLANE®-L. RESTYLANE-L is approved for implantation into the mid to deep dermis, and PERLANE-L is approved for implantation into the deep dermis to superficial subcutis, both for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.

2/1/2010
Allergan, Inc. Announces FDA Approval of JUVEDERM(R) XC Dermal Filler Formulated with Lidocaine
Allergan, Inc. Announces FDA Approval of JUVEDERM(R) XC Dermal Filler Formulated with Lidocaine

1/17/2010
FDA Shuts Down DIY Botox Web Site
Discount Medspa, a Web site that had been selling a drug similar to Botox and a range of injectable fillers, has been shut down by the FDA. The Web site was making it easy for the average consumer to purchase injectables without a prescription, which means anyone could inject themselves or someone else with a potentially harmful compound.

1/11/2010
Mechanism' therapy: Reversing the effects of environmental, genetic factors in aging skin
Over the past four decades, a great deal has been learned about the mechanisms of aging in general, and skin aging in particular, says Barbara Gilchrest, M.D., professor and chairman emeritus of dermatology, Boston University, Boston.

1/4/2010
On the mend? Fillers, toxins market resilient, due for possible bounceback, analyst says
While the worst economic slump in decades has sharply cut into consumer demand for aesthetic products, at least one analyst says there's reason to anticipate a bounceback in the coming months.

1/3/2010
Marionette lines: Targeting dynamic, static components of melomental fold rhytids
Treatment of melomental fold rhytids (marionette lines) with nonanimal sourced hyaluronic acid injectable filler (Juvéderm, Allergan) in combination with onabotulinumtoxinA (Botox Cosmetic, Allergan) may offer greater cosmetic improvement and an extended duration of benefit compared with correction using the filler alone, reports David Beynet, M.D.

12/30/2009
Women are flocking to Botox for a little holiday pick-me-up
In Canada, a legion of women investing their holiday cash on "soft lifts" with fillers such as Restylane, Radiesse and Juvederm or applications of Botox or Xeomin, which may last longer. Botox is a trade name for botulinum toxin type A, which paralyzes facial muscles so furrows and frown lines are temporarily banished.

12/22/2009
Botox Procedures Will Not Be Taxed After All
The proposed 5% tax on a wide array of botox related procedures was dropped.

12/2/2009
Help Stop the Proposed Cosmetic Tax
To help pay for the health care reform bill that is being debated over the next few weeks by the U.S. Senate, users of cosmetic medical treatments have been unfairly targeted with a 5% federal tax on such procedures.

11/19/2009
Reid Proposes a 5% Tax on Cosmetic Surgery
Senator Harry Reid’s health care bill included an array of new provisions that are being scrutinized Wednesday night, but one particular tax proposal in particular already has attracted a buzz — a 5 percent levy on elective cosmetic procedures that was quickly dubbed the “botax.

11/19/2009
Senate bill weighs on Allergan, Medicis
Allergan Inc. and Medicis Pharmaceutical Corp. led drug stocks lower early Thursday as shares of the dermatology-products makers fell on news that a new bill proposed by Senate Democrats would levy a 5% excise tax on elective cosmetic procedures.

11/17/2009
Eyes wide open: Patients, physicians embrace eyelash growth product
Since making its debut on the market this year, Latisse (bimatoprost ophthalmic solution 0.03 percent; Allergan), the first treatment approved by the Food and Drug Administration (FDA) for eyelash growth, has gained a following as a nifty new tool in the aesthetic dermatology armamentarium.

11/9/2009
Instilling Loyalty in Cosmetic Patients
Rewards programs and other referral incentives can be a boon in tough times

11/3/2009
Allergan 3Q Profit Rises 8.3% With Botox Help
Allergan Inc.'s (AGN) third-quarter profit rose 8.3% with help from rising Botox sales and while the company boosted spending on advertising as it readied for an improved economy.

10/27/2009
American Society For Aesthetic Plastic Surgery Partners With SAGE In 2010 To Publish The Aesthetic Surgery Journal
The American Society for Aesthetic Plastic Surgery (ASAPS) has partnered with SAGE to publish the Aesthetic Surgery Journal (ASJ) beginning in 2010. A peer-reviewed international journal indexed in MEDLINE/PubMed, ASJ focuses on scientific developments and clinical techniques in aesthetic surgery.

10/20/2009
Cheaper than facial surgery, Botox cosmetic injections surge in popularity
Dr. Herbert Nassour said the area and the nation have seen a surge in patients interested in getting Botox cosmetic injections, which paralyze selected facial muscles for several months and ease the appearance of wrinkles.

10/20/2009
Dysport adds new wrinkle to the search for youthful skin
Botox now has some competition. It’s another FDA-approved botulinum toxin called Dysport and it’s also used to reduce wrinkles.

10/20/2009
Botox sponge treats intrinsic rhinitis
Treating intrinsic or allergic rhinitis by injecting botulinum toxin (botox) may soon be history, for a new study has shown that sponges soaked in botox are equally effective in treating this condition.

10/15/2009
Solta Medical Announces FDA 510(k) Clearance of New Fraxel re:store(R) Dual Laser System
Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and market leader of aesthetic skin treatments, today announced it has received FDA 510(k) clearance for the new Fraxel re:store Dual laser system.

10/13/2009
Better Laser For Treating Facial Spider Veins Identified By BUSM Researchers
Researchers from Boston University School of Medicine (BUSM) have concluded that the 940nm wavelength laser is superior for treating facial spider veins (telangiectasias) as compared to the 532nm wavelength laser.

10/13/2009
Polyacrylamide Hydrogel Shows Promise As Lasting Dermal Filler
The investigational injectable filler 2.5% polyacrylamide hydrogel (AquamidR) is as effective and well tolerated as hyaluronic acid (HA, RestylaneR), for the correction of nasolabial folds, according to pivotal data released here at the 2009 American Society of Dermatologic Surgery (ASDS) meeting.

10/13/2009
Demand For Cosmetic And Surgical Procedures In Dermatologic Surgery Rising Rapidly, Researchers Find
Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000.

10/7/2009
Study: Most Women Now Consider Injectables Over Topicals
Close to 60% of women considering facial plastic surgery have delayed/postponed their procedures due to the economy.

10/7/2009
When Good Fillers Go Bad
Most cosmetic surgeons that were not "injection oriented" a decade ago now realize that fillers and neurotoxins have become an integral and necessary part of contemporary cosmetic surgery.

10/2/2009
Allergan Files Federal Lawsuit to Allow Sharing Off-Label Use
Allergan files suit to allow it to share pertinent information regarding off-label usage of BOTOX with medical providers.

9/22/2009
Petition to Stop "BOTOX tax" Now Online
An online petition has been launched to allow physicians and others to voice their opinion about the so-called Botox Tax.

9/21/2009
Nevada Governor Pushes for Botox Controls
Nevada Gov. Jim Gibbons has endorsed a proposed regulation to allow tighter controls over who may administer Botox treatments in his state.

9/12/2009
COSMETIC USE OF SCULPTRA NOW FDA APPROVED
Sculptra, a poly-L-lactic acid filler previously approved for loss of facial fat in HIV positive individuals, is now approved for cosmetic use, to add volume and fullness to facial features and contours.

7/22/2009
Better than Botox?
A look at Botox vs. Dysport

5/19/2009
Sleep May Be Factor In Weight Control
Could sleep be a critical component to maintaining a healthy body weight?

5/19/2009
FDA approves Dysport for therapeutic, aesthetic uses
Medicis (NYSE:MRX) and Ipsen (Euronext:IPN) announced the U.S. Food and Drug Administration's (FDA) approval of the Biologics License Application (BLA) for Dysport (abobotulinumtoxinA), an acetylcholine release inhibitor and a neuromuscular blocking agent, according to GlobeNewswire.com.

3/23/2009
PREVIEW-Medicis Botox rival likely to clear FDA hurdle in H2
Reloxin approval may be delayed by a quarter or more

2/20/2009
Boytox: Botox for Men
Time Magazine discusses the increase usage of Botox by Men

2/19/2009
Wrinkles Removed With Protein RHAMM, Study Shows
Research at Berkeley Lab suggests that a protein linked to the spread of several major human cancers may also hold great potential for the elimination of wrinkles and the rejuvenation of the skin.

2/19/2009
Study Demonstrates Restylane(R) Effect Lasted 18 Months In 97% Of Patients With One Repeat Injection
Restylane(R) is the only HA filler with an 18-month FDA-approved duration claim.

1/19/2009
FDA Oks New Drug that Lengthens Eye Lashes
Latisse, a new eyelash-lengthening drug is approved by the FDA.

1/19/2009
Partygoers turn to Botox to look their best
Washington DC and other major cities are seeing an increase in cosmetic procedures as the Inauguration date approaches.

1/19/2009
FDA Extends Review of Reloxin until April 13, 2009
Ipsen announced that the FDA extended review of Reloxin until April 13, 2009

12/15/2008
Fill'er Up!
This article, written by Susan Hollis, reports the increase in dentists administering Botox to their patients.

12/15/2008
Keeping the Weight Off: Which Obesity Treatment is Most Successful?
This article looks at the the long-term success rates of losing weight by switching to a healthy diet and exercise.

12/15/2008
Artefill Maker Files Bankruptcy, Fires Staff
Artes Medical files for Chapter 7 Bankruptcy

11/21/2008
Put the Best Face on Selling Skin Care
Donald J. Capuano, MD discusses the ins and outs of selling skin care in an medical aesthetic office including marketing, choosing the skin care line and personalized product lines.

11/21/2008
Problems reported with wrinkle fillers in U.S.
The FDA meets with a panel of specialists to look at the side effects of dermal fillers.

11/21/2008
Plastic Surgeons Warn Of Malnutrition In Body Contouring Patients
This article addresses the importance of detecting malnutrition before advising weight loss or body contouring procedures.

11/21/2008
Artes Medical Announces Completion of Enrollment in 1,000 Patient Post-Marketing ArteFill Study
Post-marketing study begins on paitents who received ArteFill, the only FDA approved non-resorable dermal filler.

11/20/2008
"Physician Wars" Heat Up (Again)
Edward B. Lack discusses the not so pleasent results of a hurting economy.

11/20/2008
Botox Nation: How One Drug Fixes So Many Problems
BOTOX is examined in its ability to treat multiple medical conditions as well as to be used as a facial aesthetic.